<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001967150</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001672619</issuerCik>
      <issuerName>Enliven Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39247</secFileNumber>
      <issuerAddress>
        <com:street1>6200 LOOKOUT ROAD</com:street1>
        <com:city>BOULDER</com:city>
        <com:stateOrCountry>CO</com:stateOrCountry>
        <com:zipCode>80301</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>720-647-8519</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Lyssikatos Joseph P</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Ave</com:street1>
          <com:street2>4th Fl</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>12500</noOfUnitsSold>
      <aggregateMarketValue>249125.00</aggregateMarketValue>
      <noOfUnitsOutstanding>59000000</noOfUnitsOutstanding>
      <approxSaleDate>09/19/2025</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>09/01/2019</acquiredDate>
      <natureOfAcquisitionTransaction>Founder shares</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Enliven Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>12500</amountOfSecuritiesAcquired>
      <paymentDate>09/01/2019</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Rd</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc</securitiesClassTitle>
      <saleDate>07/21/2025</saleDate>
      <amountOfSecuritiesSold>12000</amountOfSecuritiesSold>
      <grossProceeds>278646.38</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Rd</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc</securitiesClassTitle>
      <saleDate>08/19/2025</saleDate>
      <amountOfSecuritiesSold>5000</amountOfSecuritiesSold>
      <grossProceeds>98117.55</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Rd</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc</securitiesClassTitle>
      <saleDate>08/21/2025</saleDate>
      <amountOfSecuritiesSold>7500</amountOfSecuritiesSold>
      <grossProceeds>150099.08</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>All sales are to be made pursuant to a previously signed/adopted 10b5-1 selling plan dated 11/15/2024, and all representations regarding material non-public information were made as of the adoption of the plan. The shares in this filing will be sold from The Lyssikatos Revocable Trust UAD 12/15/11.</remarks>
    <noticeSignature>
      <noticeDate>09/19/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>11/15/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>Joseph Lyssikatos</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
